AI-generated analysis. Always verify with the original filing.
Capricor Therapeutics, Inc. furnished its Fourth Quarter and Full Year 2025 results via Exhibit 99.1 press release under Item 2.02. This disclosure provides investors with the company's financial performance for the reported periods.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed to be filed for purposes of Section 18 of the Sec
Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release, titled “Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Pr